Ireland’s Mr IPO and his plans to make more companies public
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Open Orphan
Hvivo chairman Cathal Friel sells remaining shares for €7.3m
Businessman oversaw the initial flotation in 2019 of clinical trials group that became Hvivo
Pharmaceutical services company Hvivo sells almost 30m placing shares
New and existing institutional investors indicated demand for shares was in excess of those available
Hvivo signs €7.3m contract to test cold virus treatment
Pharmaceutical services company is testing drug for human rhinovirus in human challenge trial
Poolbeg Pharma uses AI to identify potential drug targets for flu treatment
Biopharmaceutical company hails work with CytoReason as ‘significant breakthrough’
Hvivo inks €5.9m contract with Asia-Pacific biotech to test vaccine
Deal is Dublin-listed pharma company's first in the region in over 10 years
Poolbeg Pharma sees artificial intelligence breakthrough in RSV drug discovery
Company has been working with OneThree Biotech to us artificial intelligence to identify novel drug targets for RSV treatment
Open Orphan appoints Stephen Pinkerton as chief financial officer
Leo Toole has stepped down from the board and CFO role to pursue other interests, company announced on Monday
Open Orphan subsidiary signs deal with global pharma company
Deal will see hVivo manufacture virus for use in human challenge studies
Open Orphan subsidiary signs €6m contract for respiratory study
Company expects revenues from the contract to be recognised across 2022 and 2023
Open Orphan appoints Yamin Khan as new chief executive
Cathal Friel to continue in executive chairman role under new management structure
Potential RSV vaccine achieves regulatory step in US
Bavarian Nordic vaccine candidate used hVivo challenge trial to gather data
Open Orphan subsidiary wins $13.4m contract with US biotech company
Executive chairman Cathal Friel said Hvivo expects to sign a number of similar contracts
Open Orphan subsidiary signs €6.7m contract for flu study
Influenza could be a major global issue due to low immunity caused by reduced infection
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices